# Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants

> **NCT00548054** · PHASE2 · UNKNOWN · sponsor: **International Vaccine Institute** · enrollment: 300 (estimated)

## Conditions studied

- Cholera
- Diarrhea
- Vibrio Infections

## Interventions

- **BIOLOGICAL:** Bivalent killed oral cholera vaccine
- **BIOLOGICAL:** Killed Escherichia coli K12 placebo

## Key facts

- **NCT ID:** NCT00548054
- **Lead sponsor:** International Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548054, "Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00548054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*